Loading, please wait ...

News Analytics

The WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Susceptible Tuberculosis Treatment informs health care professionals in Member States on how to improve treatment and care for patients with drug susceptible TB (DS-TB). This document includes two new recommendations - for the use of a 4-month regimen composed of rifapentine, isoniazid, pyrazinamide, and moxifloxacin and another 4-month regimen for treatment ...

The Angle

Subject Matter

  • Healthcare 100.00%
    • Hospitals, doctors and medical care 52.38%
    • Health, disease and medicine 47.62%

Emotional Reaction






Depth Chart

Here we provide depth for the multitude of dimensions lacing this article.

Connect your favorite information below with the lead sentence at the top of the page to build a mental model of the story.